Max Robotics — Global Service Robot Directory + US Certification

About

Mark P. Callery is a leading figure in pancreatic surgery, renowned for advancing minimally invasive techniques and evidence-based guidelines. His primary research focuses on robotic and laparoscopic pancreas resection, stereotactic body radiotherapy for pancreatic cancer, and perioperative pain management. Dr. Callery’s most impactful contribution is his leadership in developing the Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection (2019), which has garnered 478 citations and serves as a global standard for safe, effective practice. He also pioneered the use of stereotactic body radiotherapy combined with gemcitabine for locally advanced pancreatic cancer (232 citations), offering new hope for patients with challenging tumors. Beyond these landmark studies, Dr. Callery has advanced robotic surgery for benign duodenal tumors and median arcuate ligament release, and he developed procedure-specific training programs for robot-assisted distal pancreatectomy to enhance surgical quality. His work on transversus abdominis plane blocks to reduce pain and narcotic use after robotic surgery further underscores his commitment to improving patient recovery. With over 800 citations across his most-cited papers, Dr. Callery’s research has profoundly shaped modern pancreatic surgery, blending innovation with rigorous clinical validation.